Member Info for EmeraldCarrots

Hmm...

Cancer analysis breakthrough.

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

===========

ANGLE Chief Executive, Andrew Newland, added:

"We see a substantial opportunity for both ANGLE and Illumina to work closely together and are grateful to Illumina for the opportunity to present our DNA dual analysis data at their webinar hosted by the highly rated EACR."

===========

Nearly a month ago now. Just a matter of time until some sort of deal is done here. Illumina have a market cap of about 18 Billion dollars. Anyone selling AGL shares is crazy IMHO.

All IMHO.

You ask me. A definate NO!!

All IMHO.

Nashwan123.

I think that selling was a massive mistake. A deal with Illumina is extremely likely if not inevitable. I wish you well nevertheless. A commercial deal should put the sp north of 20p.

All imho.

Almost certainly it will involve one of these Companies:-

1. Illumina.

2. One of Illumina's competitors in the CtDna analysis industry.

3. Astrazeneca.

4. Eisai Inc.

Very exciting times for Angle Plc. Sp is primed for blast off IMHO.

Traction to gather pace. All the ingredients are practically in place:-

1. Contract with Eisai (market cap $15 Billion).

2. Two contracts with Astrazeneca (market cap $200 Billion).

3. Tie up with Illumina (market cap $18 Billion) to help market the CTC/CtDna cancer analysis breakthrough.

Angle's sales side now has loads to play with. Other big contracts MUST be on the way.

I don’t see how they cannot land some huge contracts going forward.

All IMHO.

You post "BP's"? I find people that assume everyone knows what they mean when they post things like this "BP's" are irritating. Why do you assume everyone knows what you mean. Says a lot about your attitude is you ask me.

For lung cancer (using the Illumina lung cancer assay panel) detects around DOUBLE the number of biomarkers CtDna analysis ON ITS OWN does. The lung cancer one is just the start. Breast cancer, Ovarian, Prostate etc.. to come. So, what do the other CtDna analysis Co's do? Ignore? Oh, they tried I think, but now Illumina have confirmed it really works, and they are working with Angle........... Does the market NOT believe Illumina, Angle or the other independent Co's that have now confirmed then? Are they stupid or something? Maybe just waiting for the 1st major commercial deal.......... possibly. Set to double/triple or more..........?? THE MARKET IS ASLEEP.

All IMHO.

To revolutionise? Google:-

"What is the current market size of the Global Circulating Tumor DNA (ctDNA) Market? The Global Circulating Tumor DNA (ctDNA) Market size was valued at USD 19.76 USD Billion in 2024."

This whole situation is completely bonkers/mad/insane. The market is ***ASLEEP***/comatose/in another dimention. Words cannot portray how low Angle Plc's sp is. Why on earth can the market NOT see???????????????!!!!!!!!!!!!!

All IMHO.

Is absolutely massive for Angle Plc. The CTC DNA / ctDNA combined profiling (Angle also call it dual analysis) breakthrough enables finding about DOUBLE the amount of biomarkers in a cancer to guide treatment. About DOUBLE the chance of discovering a person’s cancer CAN be targeted with one of the modern cancer drugs as compared to CtDna analysis ALONE. It's hardly surprising that this caught Illumina's attention!! Not the mention all the other companies that already offer CtDna analysis! Thermo Fisher being but one. THIS IS ABSOLUTELY MASSIVE NEWS. The market is ASLEEP. Angle are likely to get a bid at any moment as the CtDna analysis Co's MUST get this dual analysis option or THEY WILL GET LEFT BEHIND.

All IMHO.

Scroll down to Angle, then click on play. They have improved the presentation. Even better than before now.

https://emerginggrowth.com/emerging-growth-conference-79/

Endorsing Angle's dual CTC and CtDna analysis still not taken on board! I suppose you must have followed Angle for a while to understand how significant this is to them. The market clearly simply does NOT understand. The penny will drop eventually. Orders will pick up, then snowball. This is a World wide cancer breakthrough!

All IMHO.

Bought out by the summer IMHO. Or a bid might have failed leaving the sp at more like 50p a share showing more like Angle's true worth. The sp is ludicrously low now Illumina have endorsed Angle's dual analysis method doubling the chances of finding targetable cancer biomarkers.

All IMHO.

Logistics coordinator and senior manufacturing manager. No doubt the likes of posters like TwoGood2Die (who surely must have a massive short bet on Angle Plc, LOL!) would have us believe the vacancies are because people have left fearing the worst,........... LOL!!!! Or maybe they need more staff because 3 weeks ago Illumina (market cap 21 BILLION $) endorsed Angle's "dual analysis" method of identifying cancer biomarkers? I mean is there a chance the orders have picked up, somewhat? LOL!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

All IMHO.

Operator, logistics coordinator and senior manufacturing manager. No doubt the likes of posters like TwoGood2Die (who surely must have a massive short bet on Angle Plc, LOL!) would have us believe the vacancies are because people have left fearing the worst,........... LOL!!!! Or maybe they need more staff because 3 weeks ago Illumina (market cap 21 BILLION $) endorsed Angle's "dual analysis" method of identifying cancer biomarkers? I mean is there a chance the orders have picked up, somewhat? LOL!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

All IMHO.

Sequencer. Parsortix machine $70,000 to $80,000. The "NextSeq 2000 has a list price of $335,000" !!!

So paying around $75,000 to find about double the amount of cancer biomarkers in a cancer that might be targeted with modern drugs suddenly does not seem expensive!

All IMHO.

In the EACR-Illumina webinar on 6 February the lady said they are looking at this. Following successful using the Illumina lung cancer panel to find double the number of biomarkers the lady did say they are looking at one for brain cancer. The 6th Glioblastoma Drug Development Summit is starting today, and I understand Angle present tomorrow. An RNS seems quite possible.

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

All IMHO.

We will see.

In case u missed this:-

Angle attending & partnering :

https://glioblastoma-drugdevelopment.com/partner/partners/

/follow Angle Plc.